Viread and Fluocinonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viread (tenofovir disoproxil fumarate) and Fluocinonide (fluocinonide). Common drug interactions include anxiety among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Viread and Fluocinonide. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.



On Jul, 12, 2026

38 people who take Viread and Fluocinonide together, and have interactions are studied.

Viread and Fluocinonide drug interactions.

What are the common drug interactions of Viread and Fluocinonide, by gender? *:

female:

  1. Anxiety
  2. Emotional distress
  3. Pain
  4. Bone density decreased
  5. Depression
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Arthralgia (joint pain)
  8. Osteonecrosis (death of bone)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Chronic kidney disease

male:

  1. Emotional distress
  2. Pain
  3. Bone loss
  4. Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
  5. Asthenia (weakness)
  6. Osteoporosis (bones weak and more likely to break)
  7. Bone metabolism disorder
  8. Nephropathy (damage to or disease of a kidney)
  9. Osteonecrosis (death of bone)
  10. Back pain

What are the common drug interactions of Viread and Fluocinonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Asthenia (weakness)
  2. Chronic kidney disease
  3. Emotional distress
  4. Fatigue (feeling of tiredness)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Pain
  7. Renal impairment (severely reduced kidney function)
  8. Urinary tract infection
  9. Anaemia (lack of blood)
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

30-39:

  1. Anxiety
  2. Bone density decreased
  3. Emotional distress
  4. Pain
  5. Depression
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Osteonecrosis (death of bone)
  8. Arthralgia (joint pain)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Bone loss

40-49:

  1. Abdominal distension
  2. Asthenia (weakness)
  3. Constipation
  4. Decreased appetite
  5. Dermatitis allergic (inflammation of the skin due allergic reaction)
  6. Drug resistance (reduction in effectiveness of a drug)
  7. Erythema (redness of the skin)
  8. Gastric varices
  9. Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
  10. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)

50-59:

  1. Chronic kidney disease
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Renal failure (kidney dysfunction)
  7. Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
  8. Bone metabolism disorder
  9. Bone density decreased
  10. Bone loss

60+:

  1. Emotional distress
  2. Pain
  3. Back pain
  4. Renal failure (kidney dysfunction)
  5. Bone loss
  6. Nausea (feeling of having an urge to vomit)
  7. Osteonecrosis (death of bone)
  8. Osteoporosis (bones weak and more likely to break)
  9. Renal cyst (kidney cyst)
  10. Spinal compression fracture (fracture due to spinal compression on bone)

What are the existing conditions these people have? *

  1. Hiv Infection: 32 people, 84.21%
  2. Pain: 7 people, 18.42%
  3. Hypersensitivity: 7 people, 18.42%
  4. Infection: 5 people, 13.16%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 13.16%
  6. High Blood Pressure: 5 people, 13.16%
  7. Stress And Anxiety: 4 people, 10.53%
  8. Depression: 4 people, 10.53%
  9. Inflammation: 4 people, 10.53%
  10. Bacterial Infection: 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Viread and Fluocinonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Viread and Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viread and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluocinonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tenofovir disoproxil fumarate and fluocinonide (the active ingredients of Viread and Fluocinonide, respectively), and Viread and Fluocinonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: